Cancer Survivors Program

Recruiting now · Not applicable

Conditions studied: Prostate Cancer Patients, Breast Cancer Patients

In brief

The questionnaire for assessment of adverse events after completion of cancer treatment, which is being piloted at the Masaryk Memorial Cancer Institute, aims to detect a wide range of adverse effects early on, thus facilitating adequate intervention and planning of follow-up care for all cancer survivors.

Key facts

Study ID

NCT07253987

Run by

Masaryk Memorial Cancer Institute

People needed

200

Starts

2025-05-05

Expected to finish

2026-12-31

Last updated by the study team

2026-06-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• The patient understands the information provided and agrees to participate in the study.
• Age 18 years or older.
• Histologically confirmed invasive breast cancer or invasive prostate cancer.
• Completion of the acute phase of curative oncological therapy:
• for breast cancer: curative surgery performed + completed neoadjuvant/adjuvant chemotherapy and completed adjuvant radiotherapy, if indicated
• for prostate cancer: completed radiotherapy with curative intent or radical prostatectomy performed (open, laparoscopic, robotic) or completed adjuvant radiotherapy after prostatectomy
• The patient is available for follow-up within 12 months of enrollment in the study.

You may not qualify if…

• Active ongoing oncological therapy (except for (i) adjuvant hormone therapy, (ii) adjuvant targeted therapy (anti-HER2 therapy, CDK4/6i, PARPi, T-DM1), (iii) adjuvant immunotherapy)
• Neoadjuvant/adjuvant therapy did not include chemotherapy (breast cancer).
• Recurrence of cancer
• Metastatic disease
• History of other primary malignancy (except for non-melanoma skin cancer)

Where it is running

• Masaryk Memorial Cancer Institute — Brno, Czechia (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.